Pure Global

Contouring Conformance comparing Barrigel® with Surgical Clips for Post-Lumpectomy Cavity Delineation in Breast Cancer - Trial ANZCTR12623000470695

Access comprehensive clinical trial information for ANZCTR12623000470695 through Pure Global AI's free database. This Not Applicable trial is sponsored by Austin Health and is currently Recruitment Completed. The study focuses on breast cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Australian New Zealand Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
Device Trial
ANZCTR12623000470695
Not Applicable
Recruitment Completed
Device Trial
device
Trial Details
Australian New Zealand Clinical Trials RegistryANZCTR12623000470695
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Contouring Conformance comparing Barrigel® with Surgical Clips for Post-Lumpectomy Cavity Delineation in Breast Cancer

Study Focus

breast cancer

Interventional

device

Sponsor & Location

Austin Health

Austin Health;; Palette Life Sciences

Australia

Timeline & Enrollment

Not Applicable

May 28, 2021

Aug 17, 2022

Primary Outcome

Inter-observer variability of the delineated tumour bed using the overlap difference of contours using clips and CT versus gel and MRI.

Summary

This study aims to determine whether Barrigel (hyaluronic acid gel) can delineate the tumour bed after breast cancer surgery Who is it for? You may be eligible to join this study if you have been diagnosed with early breast cancer and planned for wide local excision (WLE) and sentinel lymph node biopsy (SLNB) Study details All participants in this study will have both Barrigel and standard surgical clips applied following wide local incision of the breast cancer. Approximately 4-6 weeks after surgery (or after chemotherapy if needed), participants will undergo computed tomography (CT) scans and magnetic resonance imaging (MRI) scans to visualise the gel and clip placements. A group of doctors will then independently contour out where they think the tumour bed is, and the degree of overlap of each contour will help determine its efficacy. Participants will then be assessed annually for up to 2 years using routine surveillance breast mammography and ultrasound to determine gel presence and characteristics over the long-term. It is hoped that this research project will provide us more information about alternative ways to improve the accuracy of post-operative radiotherapy planning and treatment in early breast cancer, especially as MRI guided planning and treatment becomes more prevalent.

ICD-10 Classifications

Malignant neoplasm of breast
Malignant neoplasm of breast
Carcinoma in situ of breast, unspecified
Malignant neoplasm: Breast, unspecified
Other carcinoma in situ of breast

Data Source

Australian New Zealand Clinical Trials Registry

ANZCTR12623000470695

Device Trial